CA Patent

CA2995094A1 — Use of crac channel inhibitors for the treatment of stroke and traumatic brain injury

Assigned to Calcimedica Inc · Expires 2017-02-16 · 9y expired

What this patent protects

Described herein are methods of treatment of stroke and traumatic brain injury comprising administration of a CRAC channel inhibitor.

USPTO Abstract

Described herein are methods of treatment of stroke and traumatic brain injury comprising administration of a CRAC channel inhibitor.

Drugs covered by this patent

Patent Metadata

Patent number
CA2995094A1
Jurisdiction
CA
Classification
—
Expires
2017-02-16
Drug substance claim
No
Drug product claim
No
Assignee
Calcimedica Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.